CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,855,106 | +24.1% | 228,983 | 0.0% | 1.21% | +47.6% |
| Q1 2023 | $10,356,901 | +11.3% | 228,983 | 0.0% | 0.82% | -42.7% |
| Q4 2022 | $9,308,159 | -25.1% | 228,983 | +20.4% | 1.43% | +15.1% |
| Q3 2022 | $12,428,000 | -36.8% | 190,183 | -41.3% | 1.24% | -37.2% |
| Q2 2022 | $19,676,000 | +30.2% | 323,783 | +34.5% | 1.98% | +14.1% |
| Q1 2022 | $15,108,000 | +12.1% | 240,683 | +35.3% | 1.73% | +6.3% |
| Q4 2021 | $13,480,000 | -60.9% | 177,883 | -42.2% | 1.63% | -49.7% |
| Q3 2021 | $34,441,000 | -30.9% | 307,700 | 0.0% | 3.24% | -13.4% |
| Q2 2021 | $49,814,000 | +32.9% | 307,700 | 0.0% | 3.74% | +157.6% |
| Q1 2021 | $37,493,000 | -31.1% | 307,700 | -13.4% | 1.45% | -38.9% |
| Q4 2020 | $54,385,000 | +38.9% | 355,200 | -24.1% | 2.38% | +16.3% |
| Q3 2020 | $39,160,000 | +13.8% | 468,200 | 0.0% | 2.04% | -40.3% |
| Q2 2020 | $34,408,000 | +73.3% | 468,200 | 0.0% | 3.42% | +65.9% |
| Q1 2020 | $19,856,000 | +20.0% | 468,200 | +72.3% | 2.06% | +6.8% |
| Q4 2019 | $16,548,000 | +48.6% | 271,700 | 0.0% | 1.93% | +218.0% |
| Q3 2019 | $11,137,000 | -13.0% | 271,700 | 0.0% | 0.61% | -41.5% |
| Q2 2019 | $12,797,000 | +31.9% | 271,700 | 0.0% | 1.04% | +19.2% |
| Q1 2019 | $9,705,000 | +25.0% | 271,700 | 0.0% | 0.87% | +19.0% |
| Q4 2018 | $7,762,000 | -35.6% | 271,700 | 0.0% | 0.73% | -31.3% |
| Q3 2018 | $12,050,000 | – | 271,700 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |